arrow
V

Vera C. Mazurak

University of Alberta
H指数:41
被引数:6,213

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Addressing the distressing: Pancreatic enzyme replacement therapy mitigates abdominal symptoms and weight loss during chemotherapy for advanced pancreatic cancer: A prospective study

应对令人痛苦的症状:胰腺酶替代疗法可缓解晚期胰腺癌化疗期间的腹部症状和体重减轻:一项前瞻性研究

2026-02-010
OAAI
The effects of docosahexaenoic acid (DHA) on plasma cytokines, oxylipins, and tumor-infiltrating lymphocytes from women with breast cancer undergoing neoadjuvant chemotherapy in the DHA-WIN trial

DHA(二十二碳六烯酸)对DHA-WIN试验中接受新辅助化疗的乳腺癌女性患者血浆细胞因子、氧化脂质和肿瘤浸润淋巴细胞的影响

2025-07-100
PRE
Association between enteral essential fatty acids and plasma phospholipid essential fatty acids related immune response in critically ill adults with COVID-19: A prospective cohort study

肠内必需脂肪酸与COVID-19危重成人血浆磷脂必需脂肪酸相关免疫反应的关联:一项前瞻性队列研究

2025-06-270
OAAI
Safety and efficacy of docosahexaenoic acid supplementation during neoadjuvant breast cancer therapy: Findings from the phase II, double-blind, randomized controlled DHA-WIN trial

二十二碳六烯酸补充剂在辅助性乳腺癌治疗期间的安全性与有效性:DHA-WIN II期双盲随机对照试验的结果

2025-06-090
OA
Type II fibre atrophy and nuclear disruption in decompensated cirrhosis

II型纤维萎缩及核破坏在失代偿期肝硬化中

2025-05-240
OAAI
Early-life feeding of arachidonic acid and docosahexaenoic acid beneficially modulated ileum and splenocyte oxylipins to support oral tolerance development in allergy-prone BALB/c mice

早期补充花生四烯酸和二十二碳六烯酸可有益地调节易过敏BALB/c小鼠回肠和脾细胞的氧化脂质,以支持口服耐受性的发展。

2025-05-230
PREAI
Novel multimodal intervention for surgical prehabilitation on functional recovery and muscle characteristics in patients with non-small cell lung cancer: study protocol for a randomised controlled trial (MMP-LUNG)

非小细胞肺癌患者围手术期功能恢复与肌肉特征的新型多模式干预:随机对照试验(MMP-LUNG)研究方案

2025-05-220
OA
Docosahexaenoic acid (DHA) supplementation attenuates changes in the concentration, phenotype, and response of immune peripheral blood cells in breast cancer patients undergoing neoadjuvant therapy. Secondary findings from the DHA-WIN trial

二十二碳六烯酸(DHA)补充剂可减轻接受新辅助治疗的乳腺癌患者外周血免疫细胞在浓度、表型及反应性方面的变化。DHA-WIN试验的次要发现

2025-05-220
OA